Lucknow, India

Shipra Srivastava

This inventor holds 1 USPTO granted patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shipra Srivastava. Retrieved from https://idiyas.com/inventor/shipra-srivastava

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shipra Srivastava: Innovator in Appetite Suppression

Introduction

Shipra Srivastava is a notable inventor based in Lucknow, India. She has made significant contributions to the field of pharmaceuticals, particularly in the development of appetite suppressants. Her innovative work aims to address obesity, a growing health concern worldwide.

Latest Patents

Shipra holds a patent for N-aryloxypropanolyl-N'-phenethyl-urea. This invention provides derivatives of N-aryloxypropanolyl-N'-phenethyl-urea, which are designed to be potent appetite suppressants for the treatment of obesity. The formula includes various substituents, such as H, trifluoromethyl, chloro, bromo, and others, which enhance the efficacy of the compound.

Career Highlights

Shipra is associated with the Council of Scientific and Industrial Research, where she has been involved in groundbreaking research. Her work has not only contributed to scientific knowledge but also has practical applications in the pharmaceutical industry.

Collaborations

Shipra has collaborated with esteemed colleagues, including Kalpana Bhandari and Chandeshwar Nath. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Shipra Srivastava's contributions to the field of appetite suppression through her patented invention highlight her role as a significant innovator. Her work continues to pave the way for advancements in obesity treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…